Cargando…
Teams in transition: Increasing role of advanced practice providers in inpatient antimicrobial use
Background: Antimicrobial stewardship strategies must be tailored to effectively engage prescribers with distinct training, experiences, and career paths. Advanced practice providers (APPs) have taken on increasing roles as primary team members in acute-care hospitals, but the impact of this practic...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594284/ http://dx.doi.org/10.1017/ash.2023.266 |
_version_ | 1785124614459883520 |
---|---|
author | Perez, Reinaldo Yarrington, Michael Deri, Connor Smith, Michael Hayes, Jillian Wrenn, Rebekah Moehring, Rebekah |
author_facet | Perez, Reinaldo Yarrington, Michael Deri, Connor Smith, Michael Hayes, Jillian Wrenn, Rebekah Moehring, Rebekah |
author_sort | Perez, Reinaldo |
collection | PubMed |
description | Background: Antimicrobial stewardship strategies must be tailored to effectively engage prescribers with distinct training, experiences, and career paths. Advanced practice providers (APPs) have taken on increasing roles as primary team members in acute-care hospitals, but the impact of this practice shift on antimicrobial prescribing is unknown. We describe longitudinal trends in antimicrobial days of therapy (DOT) by attributed provider type in 3 hospitals. Methods: We performed a retrospective time-series analysis of antimicrobial use for the 7-year period of July 2015–June 2022 to investigate the changes by provider type at 3 hospitals: a major university hospital and 2 community hospitals. DOT, antibacterial, and antifungal agent groups were defined using National Healthcare Safety Network methods. We included anti-influenza and antiherpesvirus agents in the antiviral group. We defined protected agents as those targeted by hospital antimicrobial stewardship program policy (eg, requiring preauthorization). Provider type was defined by electronic health record user profiles in 3 categories: physician, trainees (residents, fellows and medical students), and APPs (nurse practitioners, physician assistants, and nurse anesthetists). We evaluated DOT per 1,000 days present over time by agent group to assess quarterly rate trends. Then, we calculated the percentage of total DOT by provider group. We used multinomial logistic regression to measure changes in percentage DOT across the clinician groups over time using physicians as the referent. Results: Across hospitals and provider groups, we observed an overall decrease in use rates for antibacterial and protected agents (17% each) and increased use rates for antiviral agents (38%) and antifungal agents (4%) (Table 1). Baseline distribution of DOT by provider group and change in distribution over time varied by hospital and agent group (Fig. and Table 2). The largest increases in percentage DOT attributed to APPs compared with physicians occurred in the university hospital with the following average increases per quarter: 1.5% for antibacterials, 3.9% for antivirals, 3.3% for antifungals, and 3.8% for protected agents (Table 3). Community hospitals had higher initial percentage DOT attributed to physicians, but both hospitals experienced increased percentage DOT attributed to APPs. Percentage DOT attributed to trainees varied significantly across agent groups and hospitals. Conclusions: Hospitals had differing baseline patterns of DOT attributed to provider groups, but all experienced increases in DOT attributed to APPs. APPs have increasing involvement in antimicrobial use decisions and should be engaged in future antimicrobial stewardship initiatives. Disclosures: None |
format | Online Article Text |
id | pubmed-10594284 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-105942842023-10-25 Teams in transition: Increasing role of advanced practice providers in inpatient antimicrobial use Perez, Reinaldo Yarrington, Michael Deri, Connor Smith, Michael Hayes, Jillian Wrenn, Rebekah Moehring, Rebekah Antimicrob Steward Healthc Epidemiol Antibiotic Stewardship Background: Antimicrobial stewardship strategies must be tailored to effectively engage prescribers with distinct training, experiences, and career paths. Advanced practice providers (APPs) have taken on increasing roles as primary team members in acute-care hospitals, but the impact of this practice shift on antimicrobial prescribing is unknown. We describe longitudinal trends in antimicrobial days of therapy (DOT) by attributed provider type in 3 hospitals. Methods: We performed a retrospective time-series analysis of antimicrobial use for the 7-year period of July 2015–June 2022 to investigate the changes by provider type at 3 hospitals: a major university hospital and 2 community hospitals. DOT, antibacterial, and antifungal agent groups were defined using National Healthcare Safety Network methods. We included anti-influenza and antiherpesvirus agents in the antiviral group. We defined protected agents as those targeted by hospital antimicrobial stewardship program policy (eg, requiring preauthorization). Provider type was defined by electronic health record user profiles in 3 categories: physician, trainees (residents, fellows and medical students), and APPs (nurse practitioners, physician assistants, and nurse anesthetists). We evaluated DOT per 1,000 days present over time by agent group to assess quarterly rate trends. Then, we calculated the percentage of total DOT by provider group. We used multinomial logistic regression to measure changes in percentage DOT across the clinician groups over time using physicians as the referent. Results: Across hospitals and provider groups, we observed an overall decrease in use rates for antibacterial and protected agents (17% each) and increased use rates for antiviral agents (38%) and antifungal agents (4%) (Table 1). Baseline distribution of DOT by provider group and change in distribution over time varied by hospital and agent group (Fig. and Table 2). The largest increases in percentage DOT attributed to APPs compared with physicians occurred in the university hospital with the following average increases per quarter: 1.5% for antibacterials, 3.9% for antivirals, 3.3% for antifungals, and 3.8% for protected agents (Table 3). Community hospitals had higher initial percentage DOT attributed to physicians, but both hospitals experienced increased percentage DOT attributed to APPs. Percentage DOT attributed to trainees varied significantly across agent groups and hospitals. Conclusions: Hospitals had differing baseline patterns of DOT attributed to provider groups, but all experienced increases in DOT attributed to APPs. APPs have increasing involvement in antimicrobial use decisions and should be engaged in future antimicrobial stewardship initiatives. Disclosures: None Cambridge University Press 2023-09-29 /pmc/articles/PMC10594284/ http://dx.doi.org/10.1017/ash.2023.266 Text en © The Society for Healthcare Epidemiology of America 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Antibiotic Stewardship Perez, Reinaldo Yarrington, Michael Deri, Connor Smith, Michael Hayes, Jillian Wrenn, Rebekah Moehring, Rebekah Teams in transition: Increasing role of advanced practice providers in inpatient antimicrobial use |
title | Teams in transition: Increasing role of advanced practice providers in inpatient antimicrobial use |
title_full | Teams in transition: Increasing role of advanced practice providers in inpatient antimicrobial use |
title_fullStr | Teams in transition: Increasing role of advanced practice providers in inpatient antimicrobial use |
title_full_unstemmed | Teams in transition: Increasing role of advanced practice providers in inpatient antimicrobial use |
title_short | Teams in transition: Increasing role of advanced practice providers in inpatient antimicrobial use |
title_sort | teams in transition: increasing role of advanced practice providers in inpatient antimicrobial use |
topic | Antibiotic Stewardship |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594284/ http://dx.doi.org/10.1017/ash.2023.266 |
work_keys_str_mv | AT perezreinaldo teamsintransitionincreasingroleofadvancedpracticeprovidersininpatientantimicrobialuse AT yarringtonmichael teamsintransitionincreasingroleofadvancedpracticeprovidersininpatientantimicrobialuse AT dericonnor teamsintransitionincreasingroleofadvancedpracticeprovidersininpatientantimicrobialuse AT smithmichael teamsintransitionincreasingroleofadvancedpracticeprovidersininpatientantimicrobialuse AT hayesjillian teamsintransitionincreasingroleofadvancedpracticeprovidersininpatientantimicrobialuse AT wrennrebekah teamsintransitionincreasingroleofadvancedpracticeprovidersininpatientantimicrobialuse AT moehringrebekah teamsintransitionincreasingroleofadvancedpracticeprovidersininpatientantimicrobialuse |